Tag: The Doherty Institute
Victoria to develop mRNA vaccine and therapeutic manufacturing capability in Melbourne
Following the Commonwealth identifying onshore production of mRNA vaccines as a national priority, the Victorian Government has announced a multimillion investment in new critical...
Featured Article
From cost exposure to cost control: Using energy flexibility to protect margins
Electricity price volatility is reshaping the cost base of Australian manufacturing, challenging long-held assumptions that energy can be treated as a stable operational input.
